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The brain is unarguably the most complex and quite possibly the most fascinating organ in the body. It 
has inspired many generations of scientists to commit their own brain power to studying nervous system 
development, structure, and function. Unfortunately, the mysteries of the human nervous system defy 
easy exploration, but this has not deterred research in understanding neurological disease pathogenesis. 
The problem for health posed by brain disorders in the developed world and in many developing societies 
such as Mediterranean countries is demanding major important changes regarding the approach, 
efficiency, and solvency of governments, health systems, and the medical community. Research on brain 
function in health and disease is among the priorities of today’s societies, and several indicators put the 
Mediterranean research area among strategic issues for the European Union (EU).  
The Mediterranean Neuroscience Society (MNS) (https://mnsociety.live/), a member of IBRO, is highly 
active in this field and works towards three main objectives: i) strengthening exchanges between 
Mediterranean neuroscientists from more developed countries in the world; ii) promoting education in 
the neurosciences and increasing public awareness of progress in the field; iii) sustaining scientific, 
training and networking events, such as, in particular, the biennial Mediterranean Neuroscience 
Conference. 
Many South-North collaborations and networks have emerged in recent years through bilateral and multi-
lateral actions, supported by the EU or by international and national actions, whether for setting up 
teaching curricula (e.g. Tempus programs), or building human potential (e.g. FP7, H2020). Many other 
initiatives of cooperation (e.g. Neurobridges) have seen the light of day, initiated by groups of motivated 
individuals who believe in the importance of scientific cooperation as a way to alleviate political distress 
between cultures. 
The main pillar on which a government with an efficient health system has to stand on in dealing with 
brain disorders is a strong education system and research program with scientists motivated to understand 
the causes of the disease, implementing early diagnostic procedures, and discovering new and effective 
treatments to slow-down the progression of the disease, thereby reducing disability and costs, and 
increasing the quality of life of  the patients and their families. Currently, we are also in a favourable 
position to enter into two new areas of progress, such as prevention, relying on interesting new findings 
related to the molecular neuropathology and genetics of brain diseases, and also pharmacogenomics, as 
the most effective manner of optimizing drug development and therapeutics, increasing efficacy and 
safety, and reducing side-effects and unnecessary costs.  
This special issue of CNS Neuroscience and Therapeutics comprises some of the works presented at the 
last Mediterranean Conference of Neuroscience that was organized in 2017 in St. Julian’s, Malta. The 
6th Mediterranean Neuroscience Society Meeting MNS 2017 MALTA was a forum to discuss modern 
experimental and interdisciplinary approaches that have led to important new insights on the 
pathogenesis and treatment of diseases of the human central and peripheral nervous systems and explore 
new avenues for understanding the brain. The international scientific community was represented by 
scientists from 48 different countries from all over the world. It was a very successful event, both 
scientifically and socially. The MNS2017 programme included 8 plenary lectures by Giacomo Rizzolatti 
(IT/MT), Vincenzo Crunelli (UK/MT), Raphael Mechoulam (EL), Michela Matteoli (IT), Pierre J. 
Magistretti (CH), Rosa Cossart (FR), Carmen Cavada (ES), Ilana Gozes (ES) and the FENS special 
lecture by Juan Lerma, more than 60 symposia and hundreds of poster presentations which furthered 
stimulating interactions among participants. This 6th MNS Conference was surely a memorable 
experience.  
This Special Issue starts with the contribution by McCafferty and colleagues on absence seizures (ASs), 
the most common form of generalized epilepsy [1, 2]. The authors demonstrated that knocking-out the δ 
subunit of the extra synaptic GABAA receptors in the stargazer (STG) mouse, via crossbreeding them 
with δ subunit KO mice, prevented the development of ASs, thus leading to a “genetic rescue” of the 
STG epilepsy phenotype. This study is the first example of a genetic rescue of an absence seizure 
phenotype, confirming the centrality of TC neuron tonic GABAA current in the mechanisms of rodent 
ASs, and therefore suggesting that therapeutic interventions for these seizures based on the disruption of 
this current, specifically via extra synaptic GABAA receptor containing the δ subunit, hold particular 
promise.  
Apart from regulating excitability and being involved in epilepsy, the GABA system modulates several 
forebrain functions. As Olucha-Bordonau and colleagues reviewed in their contribution, an important 
GABAergic projection arises from ascending, subcortical neural projections originating in the nucleus 
incertus (NI) in the pontine tegmentum and made by large GABA neurons co-expressing neuropeptides 
including relaxin-3, cholecystokinin, and neuromedin-B. At the behavioural level, activation of the NI 
promotes locomotor activity, theta oscillations in the hippocampus phase-locked to those in the 
brainstem, spatial learning, anxiety processes, feeding behaviour and alcohol-seeking. Further 
knowledge of how this system modulates these processes may offer a new therapeutic perspective on 
treating malfunctions associated with neuropathology and psychiatric disorders. 
Florio and colleagues focus their review on basal ganglia and Parkinson's disease (PD), the most common 
movement disorder and the second most common neurodegenerative disease after Alzheimer's. The 
number of people with PD over the age of 50 will at least double by 2030 in the world's most populous 
countries [3]. Given the global phenomenon of population ageing affecting all nations, the economic 
burden of PD is expected to grow substantially in the coming decades. Unfortunately, as Florio and 
colleagues underline in their review, our understanding of the basal ganglia and in general of PD 
neuropathology is limited and therapy is only symptomatic [4]. Florio et al conclude that basal ganglia 
are more than just a switching device and suggest that the consequences of bilateral functional 
coordination loss in the progression of neurodegenerative disorders, such as PD, deserve careful 
consideration, assuming that they could emerge and develop unilaterally during the early-phase of their 
staging. Many neurotransmitter systems, apart from the dopaminergic one, seem to be involved in basal 
ganglia pathophysiology. One of the most investigated neurotransmitters is serotonin [5, 6] and its 5-
HT2C receptors [7]. Lagière et al. show that the 5-HT2C receptor agonist WAY 163909 facilitates the 
appearance of the late excitatory response (indirect pathway of the basal ganglia) of the substantia nigra 
pars reticulata neurons connected to the anterior cingulate cortex. This intriguing result might be related 
to an effect of the 5-HT2C receptor agonist in the cortex rather than in the basal ganglia.  
Another disorder that involves the basal ganglia is Tourette’s syndrome (TS), characterized by multiple 
motor and phonic tics, emerging before 18 years of age that are recapitulated by different animal models 
[8] including the D1CT-7 mouse model. As shown by Santangelo and colleagues, D1CT-7 mouse model 
is subjected to a behavioral fragmentation, with repercussions going beyond the simple tic-like 
phenomenon. These phenotypes are strikingly akin to behavioral problems observed in TS patients and 
further validate the power of this model in summarizing pivotal behavioral aspects of TS. 
The following article is on Alzheimer’s disease (AD) and dementias that are major public health 
problems, in part due to the increasing life expectancy of the population. A search for biomarkers has 
appeared to be essential for the early treatment of this devastating disease. Kiđemet-Piskač and 
colleagues confirm and extend the evidence that the cerebrospinal fluid (CSF) levels of the tau protein 
phosphorylated at threonine 231 (p-tau231) reliably differentiate patients with AD and healthy control 
subjects as they indicate that CSF p-tau231 levels can also be used for differentiating subjects with 
vascular dementia (VaD) from control subjects. Additionally, in distinguishing between AD and VaD, 
the authors established that factor score (FS) determined by combination of p-tau231 and Mini-Mental 
State Examination (MMSE) has a strong potential to offer earlier distinction between these conditions. 
This finding not only has clinical significance, but also potential to prevent development and 
complications of VaD at an early stage.  
The next article deals with one of the current hot topics in neuroscience i.e., the role of the lateral 
habenula (LHb) and the serotonergic system in depression. Delicata and co-authors show that 5-HT2A 
receptor and 5-HT2C receptor subtypes, that are thought to play a role in the mechanism of action of 
antidepressant drugs and drug of abuse [11], control the activity of LHb neurons. Most of the published 
data on 5-HT2 receptors in the LHb have up until now been interpreted in the light of 5-HT2C receptor 
subtypes, while Delicata and colleagues’ data would suggest a main role of for 5-HT2A receptors that 
might act also through the activation of the LHb 5-HT2A receptor expressed on the astrocytes.  
The selection continues with Carbone and co-authors’ behavioral study that sheds light on the role of 5-
HT7 receptor in emotional and motivational regulations as well as in processing of memory and anxiety. 
The selective agonist LP-211 exhibited a modulatory effect on motivational drives and improved both 
visuo-spatial and emotional consolidation. On the contrary, in a third experiment, it showed a very slight 
anxiolytic effect in a dark light task. 
The Special Issue ends with two reviews. The first by Rizzolatti and colleagues gives an historical 
excursus on the major advancements which have characterized system neuroscience since the golden age 
(1940-2000), through the brain imaging era and up to the modern era. In the latter, the use of multimodal 
approaches combining different recording techniques and advanced signal processing will hopefully lead 
to a better understanding of the neural mechanisms underlying neurological and cognitive functions. The 
authors believe that to this aim, the contribution offered by intracranial recordings will be fundamental, 
thanks to the possibility of detailing with a millisecond-based temporal resolution the time course of 
neural activity, and of investigating the causal relationship between the activation of cortical areas and 
the emergence of specific behavior. In addition, Rizzolatti and co-authors underline that given that 
patients undergoing stereo-EEG are free to move while being recorded, intracranial recordings should 
lead to a major step forward in the knowledge about the organization of the human motor system and the 
spatiotemporal dynamics ruling the motor contribution to cognitive functions.  
The last contribution by Khalil et al. briefly outlines the plausibility of the neural interaction between 
motor control, imitative behaviors and their impact on social decision making in Autism Spectrum 
Disorders (ASDs). Khalil and colleagues discuss the methodological approaches (i.e., fMRI and EEG 
recording as neurophysiological markers) that can be implemented to test the proposed competitive 
interactions between the mirror neuron system, the BG, and the motor cortex. 
In summary, we believe that the articles presented in this special issue provide an important update on 
the role of neurotransmitters (i.e., GABA and serotonin), brain structure and neural networks in brain 
physiology and pathology. As noted in many of the articles, brain research continues to evolve as both 
the acquisition and analyses methods develop and expand, but the existing evidence points to the 
functional relevance of understanding variations in normal development and the critical importance of 
their structural and functional brain disruption as a means of understanding pathophysiology and 
potential pathways for intervention or even prevention. The articles in this special issue are small steps 
along that path. 
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